Elizabeth Yeu Lin, Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 2,078 shares at $79.50 ($165K) on 2025-12-16, disclosed to the SEC on 2025-12-17.
Open-market sale of $165k TARS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TARS | SELL | 2026-03-19 | $78K | — | Filing → |
| TARS | SELL | 2025-06-17 | $41K | — | Filing → |
| STAA | BUY | 2023-09-22 | $100K | — | Filing → |